COVID-19 vaccine ‘Covaxin’ marks a significant milestone: Karnataka Health Minister

▴ COVID-19 vaccine ‘Covaxin’ marks a significant milestone: Karnataka Health Minister
Karnataka Minister for Health and Medical Education Dr. K. Sudhakar has come forward to negate suspicion on the Covaxin vaccine developed by Bharat Biotech.

Karnataka Minister for Health and Medical Education Dr. K. Sudhakar has come forward to negate suspicion on the Covaxin vaccine developed by Bharat Biotech.

He has appeared as a fellow medical professional to refrain from unwarranted criticism discrediting the hard work of the scientists involved in the development of the vaccine within the country.
 
In a series of tweets today, the Minister said that the COVID-19 vaccine Covaxin developed within the country marks a significant milestone. He said that India being one of the largest exporters of vaccines and the world is looking up to India in the common fight against the global pandemic.

The Minister stressed that Bharat Biotech is a globally reputed company with the credibility and experience of developing 16 vaccines including for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika, and the world’s first tetanus-toxoid conjugated vaccine for Typhoid.

 
Dr. Sudhakar informed that Bharat Biotech has delivered over four billion vaccine doses to the underprivileged people in more than 150 developing countries through UNICEF and other channels.

On the clinical trials of Covaxin, the Minister said, the Phase-3 clinical trial involves 24,000 volunteers and its data will be available soon

Tags : #KarnatakasCovid-19Update05Jan2021 #Karnataka #India #HealthandEducationMinister #DrKSudhakar #Covid-19Vaccine #BharatBiotech #Covaxin #VaccineForCovidTreatment #VaccineClinicalTrails #FightAgainstCovidVirus

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

New Milestone: First Cryopreserved Stem Cell Donation Helps Blood Cancer Patient December 13, 2024
Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in MacauDecember 13, 2024
Plastic Pollution Goes Personal: Microplastics Found in Human BloodDecember 12, 2024
The Fat-Fuelled Weapon Against Cancer: How the Keto Lifestyle is Redefining Cancer TherapyDecember 12, 2024
Gene Therapy in India: How Indian Scientists Redefined Hemophilia TreatmentDecember 12, 2024
Empowering India’s Workforce: FinX Raises $6M from Elevar Equity to revolutionise employability in the BFSI IndustryDecember 12, 2024
India’s Win Over Malaria: A Global Health Victory in ProgressDecember 11, 2024
TB-Free India by 2025: Bold Vision or Achievable Reality?December 11, 2024
Aakash Healthcare Supports the 14th Special Athletic Meet for Children with Special NeedsDecember 11, 2024
The University of Manchester invites applications for an MSc in International Disaster ManagementDecember 10, 2024
Preventing Mother-to-Child HIV Transmission: Strategies and ImportanceDecember 10, 2024
USIBC Signs MOU with Government of Telangana, Hosts AI and GCC Industry RoundtableDecember 10, 2024
CarDekho Group’s New Auto Segment’s Shift in Fuel Preferences Report: Electric Vehicles (EVs) Lead the Chart with 26% YoY Traffic Increase December 10, 2024
India’s leading eCommerce enablement platform Shiprocket appoints industry veteran Vivek Sharma as VP of International ShippingDecember 10, 2024
Failure to find all TB cases defeats us in #endTB effortsDecember 10, 2024
Fear of Missing Out or Fear of Missing Connections: How FOMO Reflects Our Need for BelongingDecember 10, 2024
Rewriting Elderly Care: Rs 5 Lakh Healthcare for India’s Elderly Through Ayushman Vay Vandana CardDecember 10, 2024
ISB DLabs in collaboration with CitiusTech launches ‘I-HEAL @ ISB 3.0’: Accelerating Digital Healthcare Innovation in IndiaDecember 10, 2024
Aditya Roy Kapur unveils PartySmart Gummies for hangover preventionDecember 10, 2024
Sightsavers India and Alcon India Inaugurate Block Resource Centre aimed to Empower Children with Visual Impairment in BankuraDecember 10, 2024